Karen McDaid

Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy

R. Swann, S. Barry, S. Wedge, 2013, Clinical Cancer Research.

CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma

A. Biankin, S. Barry, D. Chang, 2016, Cancer cell.

CXCR 2 Inhibition Profoun dly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma Graphical Abstract Highlights

A. Biankin, S. Barry, D. Chang, 2016 .

A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo

S. Barry, J. Kendrew, V. Bedian, 2013, Oncogene.

Collagen cross-linking treatment increases adhesion in mock corneal grafts.

Sanjay Mantry, K. McDaid, P. Flavahan, 2016, Contact lens & anterior eye : the journal of the British Contact Lens Association.

An Antibody Targeted to VEGFR-2 Ig Domains 4-7 Inhibits VEGFR-2 Activation and VEGFR-2–Dependent Angiogenesis without Affecting Ligand Binding

S. Barry, S. Wedge, J. Kendrew, 2011, Molecular Cancer Therapeutics.

Tumor Stromal Phenotypes Define VEGF Sensitivity—Response

X. Wang, R. Swann, S. Barry, 2014, Clinical Cancer Research.

Professional Standards and Professional Learning: A Position Paper.

Karen McDaid, 2010 .